Verona Pharma

Investment area
Novo Ventures
Region
Europe
Date of investment
June 2016

Verona Pharma (LSE: VRP) is a clinical stage biopharmaceutical company focused on the development of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, asthma and cystic fibrosis.

Verona Pharma

Investment area
Novo Ventures
Region
Europe
Date of investment
June 2016

Verona Pharma (LSE: VRP) is a clinical stage biopharmaceutical company focused on the development of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, asthma and cystic fibrosis.

Verona Pharma

Investment area
Novo Ventures
Region
Europe
Date of investment
June 2016

Verona Pharma (LSE: VRP) is a clinical stage biopharmaceutical company focused on the development of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, asthma and cystic fibrosis.